Renaissance Technologies’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-542,548
| Closed | -$20.4M | – | 3939 |
|
|
2021
Q1 | $20.4M | Sell |
542,548
-792,300
| -59% | -$19.8M | 0.03% | 755 |
|
|
2020
Q4 | $22.7M | Sell |
1,334,848
-361,338
| -21% | -$4.53M | 0.02% | 694 |
|
|
2020
Q3 | $7.97M | Sell |
1,696,186
-47,862
| -3% | -$243K | 0.01% | 1295 |
|
|
2020
Q2 | $10.6M | Sell |
1,744,048
-227,869
| -12% | -$939K | 0.01% | 1182 |
|
|
2020
Q1 | $4.48M | Buy |
1,971,917
+209,946
| +12% | +$891K | ﹤0.01% | 1634 |
|
|
2019
Q4 | $8.09M | Buy |
1,761,971
+427,080
| +32% | +$1.69M | 0.01% | 1579 |
|
|
2019
Q3 | $5.17M | Buy |
1,334,891
+185,691
| +16% | +$1.02M | ﹤0.01% | 1775 |
|
|
2019
Q2 | $6.93M | Buy |
1,149,200
+533,100
| +87% | +$5.1M | 0.01% | 1629 |
|
|
2019
Q1 | $8.26M | Buy |
616,100
+132,395
| +27% | +$1.51M | 0.01% | 1488 |
|
|
2018
Q4 | $4.5M | Buy |
483,705
+333,705
| +222% | +$3.97M | ﹤0.01% | 1797 |
|
|
2018
Q3 | $2.09M | Sell |
150,000
-73,800
| -33% | -$1.1M | ﹤0.01% | 2248 |
|
|
2018
Q2 | $3.54M | Sell |
223,800
-145,400
| -39% | -$2.54M | ﹤0.01% | 1978 |
|
|
2018
Q1 | $6.34M | Buy |
+369,200
| New | +$7.2M | 0.01% | 1667 |
|
|
2017
Q4 | – | Sell |
-70,700
| Closed | -$2.89M | – | 3569 |
|
|
2017
Q3 | $2.89M | Sell |
70,700
-360,800
| -84% | -$11.3M | ﹤0.01% | 2094 |
|
|
2017
Q2 | $13M | Sell |
431,500
-31,401
| -7% | -$980K | 0.02% | 1094 |
|
|
2017
Q1 | $16.7M | Buy |
+462,901
| New | +$20.4M | 0.02% | 915 |
|
|
2016
Q4 | – | Sell |
-51,700
| Closed | -$2.71M | – | 3563 |
|
|
2016
Q3 | $2.71M | Sell |
51,700
-69,600
| -57% | -$3.32M | ﹤0.01% | 2010 |
|
|
2016
Q2 | $5.02M | Sell |
121,300
-112,000
| -48% | -$4.87M | 0.01% | 1598 |
|
|
2016
Q1 | $9.48M | Sell |
233,300
-79,900
| -26% | -$2.75M | 0.02% | 1174 |
|
|
2015
Q4 | $13M | Buy |
313,200
+281,900
| +901% | +$9.45M | 0.03% | 810 |
|
|
2015
Q3 | $482K | Sell |
31,300
-133,300
| -81% | -$2.86M | ﹤0.01% | 2643 |
|
|
2015
Q2 | $4.09M | Buy |
164,600
+21,400
| +15% | +$477K | 0.01% | 1574 |
|
|
2015
Q1 | $3.27M | Buy |
+143,200
| New | +$3.61M | 0.01% | 1643 |
|
Renaissance Technologies's FPRX Position: Q2 2021 in Review
Renaissance Technologies sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 542,548 shares — an estimated $20.4M sold.
Renaissance Technologies first reported a position in FPRX in Q1 2015 and held it in 23 quarters. The position peaked at $22.7M in Q4 2020. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Renaissance Technologies reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Renaissance Technologies sold 542,548 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $20.4M.
- Renaissance Technologies first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 23 quarters.
- Renaissance Technologies's Five Prime Therapeutics, Inc. position peaked at $22.7M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.